Teva Pharmaceuticals USA Inc. and its subsidiary Teva Neuroscience Inc. have agreed to pay $450 million to resolve civil kickback and false claims allegations related to the drug company’s alleged use of patient assistance foundations to cover its customers’ Medicare co-pays and an alleged conspiracy with other generic drug manufacturers to fix the prices of their products (Un... Read More